ロード中...
The place of intravenous immunoglobulin in rheumatic diseases
Therapy with intravenous human immunoglobulin (IVIG) was and continues to remain essential for a number of diseases. At the same time the evidence base for IVIG use is extremely small in rheumatology. Clinical experience shows that IVIG is effective in treating thrombocytopenic purpura, Guillain–Bar...
保存先:
主要な著者: | , , |
---|---|
フォーマット: | Artigo |
言語: | Russo |
出版事項: |
IMA-PRESS LLC
2016-01-01
|
シリーズ: | Современная ревматология |
主題: | |
オンライン・アクセス: | https://mrj.ima-press.net/mrj/article/view/655 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|